IMMUNIC INC Share Price Today: Live Updates & Key Insights

IMMUNIC INC share price today is $1.08, up -5.17%. The stock opened at $1.145 against the previous close of $1.16, with an intraday high of $1.16 and low of $1.075.

IMMUNIC INC Share Price Chart

IMMUNIC INC

us-stock
To Invest in {{usstockname}}
us-stock

IMMUNIC INC Share Price Performance

$1.08 -0.0517(-5.17%) IMUX at 23 Mar 2026 01:39 PM Biotechnology
Lowest Today 1.075
Highest Today 1.16
Today’s Open 1.145
Prev. Close 1.16
52 Week High 1.51
52 Week Low 0.51
Day’s Range: Low 1.075 High 1.16
52-Week Range: Low 0.51 High 1.51
1 day return -
1 Week return -6.89
1 month return +24.12
3 month return +79.97
6 month return +20.81
1 year return -8.08
3 year return -31.64
5 year return -93.03
10 year return -

IMMUNIC INC Institutional Holdings

Aberdeen Group PLC 6.32

Bvf Inc 5.87

Vanguard Group Inc 3.85

abrdn Healthcare Investors 3.63

Avidity Partners Management LP 3.60

Nantahala Capital Management, LLC 3.36

Millennium Management LLC 2.62

Morgan Stanley - Brokerage Accounts 2.38

abrdn Life Sciences Investors 2.32

The Colony Group LLC 1.98

Vanguard Total Stock Mkt Idx Inv 1.97

LAURION CAPITAL MANAGEMENT LP 1.44

Soleus Capital Management, L.P. 1.21

Vanguard Institutional Extnd Mkt Idx Tr 1.16

Adage Capital Partners Gp LLC 1.07

Geode Capital Management, LLC 0.90

Marshall Wace Asset Management Ltd 0.78

Ikarian Capital, LLC 0.70

BlackRock Inc 0.56

Fidelity Extended Market Index 0.50

GSA Capital Partners LLP 0.40

abrdn World Healthcare 0.37

Simplify Propel Opportunities ETF 0.27

Squarepoint Ops LLC 0.27

Susquehanna International Group, LLP 0.26

State Street Corp 0.25

Connective Capital Management LLC 0.23

Blackrock Extended Mkt Fund CF 0.20

iShares Micro-Cap ETF 0.20

Extended Equity Market Fund K 0.18

Fidelity Total Market Index 0.12

Vifag 2002 SICAV 0.10

Fidelity Series Total Market Index 0.10

Spartan Extended Market Index Pool F 0.09

Vanguard Instl Ttl Stck Mkt Idx Tr 0.09

NT Ext Equity Mkt Idx Fd - NL 0.09

Northern Trust Extended Eq Market Idx 0.08

NT Ext Equity Mkt Idx Fd - L 0.08

Vanguard Balanced Index Inv 0.07

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.07

IMMUNIC INC Market Status

Strong Buy: 5

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

IMMUNIC INC Fundamentals

Market Cap 143.51 M

PB Ratio 12.717

PE Ratio 0.0

Enterprise Value 128.61 M

Total Assets 24.05 M

Volume 2024336

IMMUNIC INC Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-128514000 -128.5M, FY22:-154296000 -154.3M, FY21:-92794000 -92.8M, FY20:-43959000 -44.0M, FY19:-34826000 -34.8M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:-43000 -0.0M, Q1/2025:-43000 -0.0M, Q3/2024:null 0.0M, Q2/2024:-31000 -0.0M

Quarterly Net worth Q3/2025:-25579000 -25.6M, Q2/2025:-26820000 -26.8M, Q1/2025:-25473000 -25.5M, Q3/2024:-24368000 -24.4M, Q2/2024:-21380000 -21.4M

About IMMUNIC INC & investment objective

Company Information Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical and phase 2 clinical development for patients with relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company also develops IMU-856, which is entering Phase 2 clinical trial, for the restoration of the intestinal barrier function in patients suffering from gastrointestinal diseases, such as celiac disease, inflammatory bowel disease, short bowel syndrome, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases; and IMU-381, which is in preclinical trial, for the treatment of gastrointestinal diseases. Immunic, Inc. was founded in 2016 and is headquartered in New York, New York.

Organisation Biotechnology

Employees 92

Industry Biotechnology

CEO Dr. Daniel Vitt Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

IMMUNIC INC FAQs

What is the share price of IMMUNIC INC today?

The current share price of IMMUNIC INC is $1.08.

Can I buy IMMUNIC INC shares in India?

Yes, Indian investors can buy IMMUNIC INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy IMMUNIC INC shares in India?

You can easily invest in IMMUNIC INC shares from India by:

Can I buy fractional shares of IMMUNIC INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of IMMUNIC INC?

IMMUNIC INC has a market cap of $143.51 M.

In which sector does IMMUNIC INC belong?

IMMUNIC INC operates in the Biotechnology sector.

What documents are required to invest in IMMUNIC INC stocks?

To invest, you typically need:

What is the PE and PB ratio of IMMUNIC INC?

The PE ratio of IMMUNIC INC is N/A and the PB ratio is 12.72.